@pemile

Je regarde votre premier lien, aucun rapport avec l’HCQ ??!!

Table 4 shows the management given to hospitalized patients. Almost all patients were given LMWH and antibiotics, with all males receiving the latter (p=0.02). Majority (∼97%) also received vitamin C, vitamin D and azithromycin. Majority also received hydroxychloroquine (89%) and dexamethasone (68.7%).

Table 5 ...
... Among the treatment options, patients who were given methylpredinosolone, dexamethasone, hydroxychloroquine and azithromycin were significantly less likely to die from Covid-19 by as much as 65%, 80%, 88% and 97%, respectively.

3. Discussion
....

Worthy to mention are the protective effects of corticosteroids (dexamethasone and methylprednisolone) as well as hydroxychloroquine from severe Covid-19 outcomes. Hydroxychloroquine in particular protects from Covid-19 death by 88% in the dataset studied. This percentage, while much higher compared to other recent studies done elsewhere [16], [17], [18], reiterates that the use of hydroxychloroquine is associated with reduced Covid-19 mortality. Several studies however do not consider the use of hydroxychloroquine beneficial for Covid-19 treatment [19], [20]. These differences can be partly explained by differences in research methods, some of which were flawed and biased given the premature media attention it received prior to approval [21]. The use of hydroxychloroquine however in Saudi Arabia is approved by the Ministry of Health.
....

Donc si il y en a un qui se fout de la gueule de l’autre c’est bien vous.
Vous êtes pénible ...
Avant d’écrire apprenez à lire sinon je vais croire que vous testez la dernière molécule megatroll de Big Pharma ...